J
Jennifer Y. Lin
Researcher at Brigham and Women's Hospital
Publications - 59
Citations - 4817
Jennifer Y. Lin is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 27, co-authored 56 publications receiving 4314 citations. Previous affiliations of Jennifer Y. Lin include Emmanuel College (Massachusetts) & Harvard University.
Papers
More filters
Journal ArticleDOI
Melanocyte biology and skin pigmentation
Jennifer Y. Lin,David E. Fisher +1 more
TL;DR: Pigmentation mutants in various species are highly informative about basic genetic and developmental pathways, and provide important clues to the processes of photoprotection, cancer predisposition and even human evolution.
Journal ArticleDOI
Central Role of p53 in the Suntan Response and Pathologic Hyperpigmentation
Rutao Cui,Hans R. Widlund,Erez Feige,Jennifer Y. Lin,Dara L. Wilensky,Viven E. Igras,John A. D'Orazio,Claire Y. Fung,Carl F. Schanbacher,Scott R. Granter,Scott R. Granter,David E. Fisher +11 more
TL;DR: In this paper, the authors provided biochemical and genetic evidence demonstrating that UV induction of POMC/MSH in skin is directly controlled by p53 and that absence of p53, as in knockout mice, is associated with absence of the UV-tanning response.
Journal ArticleDOI
The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.
JoAnn E. Manson,Shari S. Bassuk,I-Min Lee,I-Min Lee,Nancy R. Cook,Nancy R. Cook,Michelle A. Albert,David Gordon,Elaine Zaharris,Jean G. MacFadyen,Eleanor Danielson,Jennifer Y. Lin,Shumin M. Zhang,Julie E. Buring,Julie E. Buring +14 more
TL;DR: The ongoing VITamin D and OmegA-3 TriaL (VITAL) is a large randomized, double-blind, placebo-controlled, 2 x 2 factorial trial of vitamin D and marine omega-3 fatty acids in the primary prevention of cancer and CVD among a multi-ethnic population of 20,000 U.S. men aged ≥ 50 and women aged ≥ 55.
Journal ArticleDOI
Vitamins C and E and Beta Carotene Supplementation and Cancer Risk: A Randomized Controlled Trial
Jennifer Y. Lin,Nancy R. Cook,Christine M. Albert,Elaine Zaharris,J. Michael Gaziano,Martin Van Denburgh,Julie E. Buring,JoAnn E. Manson +7 more
TL;DR: In the Women's Antioxidant Cardiovascular Study (WACS) as mentioned in this paper, a double-blind, placebo-controlled 2 × 2 x 2x 2 factorial trial of vitamin C (500 mg of ascorbic acid daily), natural-source vitamin E (600 IU of alpha-tocopherol every other day), and beta carotene (50 mg every other daily), 7627 women who were free of cancer before random assignment were selected for this study.
Journal ArticleDOI
Intakes of calcium and vitamin D and breast cancer risk in women.
TL;DR: In this article, the authors evaluated total calcium and vitamin D intake in relation to breast cancer incidence among 10,578 premenopausal and 20,909 postmenopausal women 45 years or older who were free of cancer and cardiovascular disease at baseline.